Rahimy Ehsan

Alshaikhsalama Ahmed M, Mansoor Basir S, Zaidi Zuhair, Alsoudi Amer, Loya Asad, Wai Karen et al.

YAG laser capsulotomy in NPDR patients significantly increases diabetic retinopathy progression and complications. Close ophthalmic follow-up is crucial after YAG treatment in this population.

Toth Anna B, Binczyk Natalia M, Tran Elaine M, Wai Karen M, Koo Eubee B, Kossler Andrea L et al.

Opioid prescriptions after ophthalmic surgery showed minimal pain reduction in some subspecialties, like glaucoma, but often didn't reduce ER visits and sometimes increased them, suggesting limited benefit and need for tailored pain management.

Lin Jonathan B, Wai Karen M, Mruthyunjaya Prithvi, Rahimy Ehsan

This study found over 5% of patients developed glaucoma after vitrectomy, with retinal detachment cases at higher risk, emphasizing the need for post-op glaucoma monitoring.

Zaidi Zuhair, Alshaikhsalama Ahmed, Alsoudi Amer, Rahimy Ehsan

Ahmad Baseer U, Kim Judy E, Rahimy Ehsan

Deep learning AI, especially CNNs, shows diagnostic accuracy comparable to humans for specific ophthalmic image analysis tasks like detecting various retinal diseases, aiding clinical practice.

Rahimy Ehsan, Ying Gui-Shuang, Pan Wei, Hsu Jason

This study found aqueous-suppressing glaucoma drops trended toward better vision and retinal thickness reduction in nAMD patients receiving anti-VEGF, unlike outflow-increasing drops, warranting further investigation.

Rahimy Ehsan

Deep learning accurately detects posterior eye diseases like diabetic retinopathy, AMD, and glaucoma from images, showing promise for automated diagnosis, but needs further clinical validation.

Rahimy Elham, Rahimy Ehsan

Rahimy Ehsan, Shahlaee Abtin, Khan M Ali, Ying Gui-Shuang, Maguire Joseph I, Ho Allen C et al.

Switching persistent DME patients from other anti-VEGFs to aflibercept significantly reduced macular thickness, offering anatomical improvement. Visual acuity and IOP changes were not statistically significant.

Rahimy Ehsan, Sarraf David

This review highlights how timely recognition of paraneoplastic visual disorders can lead to early cancer detection, improving survival, and discusses diagnostic challenges and autoantibody utility.